Back to top

Image: Bigstock

Encompass Health Plans a 50-Bed Unit to Better Serve North Las Vegas

Read MoreHide Full Article

Key Takeaways

  • EHC plans a 50-bed rehab hospital in North Las Vegas, set to open by 2028.
  • The facility will feature private rooms, therapy gym and 24/7 nursing and therapy services.
  • EHC's move supports its broader U.S. expansion strategy amid rising rehabilitation service demand.

Encompass Health Corporation (EHC - Free Report) recently disclosed initial plans to construct a freestanding inpatient rehabilitation hospital in North Las Vegas, NV. Equipped with 50 beds, the facility is expected to commence operations by 2028. 

The hospital will offer private patient rooms, a modern therapy gym equipped with advanced rehabilitation technologies and specialized spaces such as daily living suite and an in-house dialysis unit. Complementing these are additional amenities like an in-house pharmacy, a communal dining space and a therapeutic courtyard. 

Patients will benefit from comprehensive rehabilitative services, including round-the-clock nursing care, as well as physical, occupational and speech therapy. The care team will include highly trained physicians, therapists and nurses. This, in turn, will ensure speedy recovery of patients suffering from a range of serious health conditions and ensure their quicker return to normal daily activities.

Encompass Health’s Motive Behind the Recent Move

Encompass Health's latest announcement highlights its commitment to enhancing healthcare outcomes in the Las Vegas region, thereby reinforcing its presence throughout Nevada, where it operates three other facilities. These expansion efforts are driven by a sustained need for comprehensive rehabilitation services across various U.S. communities.

By continually growing its nationwide network of inpatient rehabilitation hospitals, Encompass Health positions itself to serve an expanding patient population and generate increased revenues. Higher patient volumes boost revenues for any healthcare operator like EHC. In the first quarter of 2025, Encompass Health reported $1.5 billion in revenues from inpatient rehabilitation services, reflecting 10.6% year-over-year growth.

Currently, the company operates 168 inpatient rehabilitation hospitals across 38 states and Puerto Rico. This expansive portfolio is the result of a proactive growth strategy that includes both independently developed facilities and also facilities built through partnerships with regional healthcare providers. These collaborations offer strategic advantages by enabling Encompass Health to gain deeper insights into the unique healthcare needs of different regions. The last addition to its hospital portfolio was that of Rehabilitation Hospital of Fort Myers, which was built in partnership with Lee Health to provide high-quality rehabilitation services across Florida.

EHC’s Share Price Performance & Zacks Rank

Shares of Encompass Health have gained 41.8% in the past year compared with the industry’s 3.6% growth. EHC currently sports a Zacks Rank #1 (Strong Buy).

Zacks Investment Research
Image Source: Zacks Investment Research

Other Stocks to Consider

Some other top-ranked stocks in the Medical space are Integer Holdings Corporation (ITGR - Free Report) , Align Technology, Inc. (ALGN - Free Report) and BioLife Solutions, Inc. (BLFS - Free Report) , each currently sporting a Zacks Rank of 1. You can see the complete list of today’s Zacks #1 Rank stocks here.

Integer’s earnings surpassed estimates in three of the last four quarters and missed the mark once, the average surprise being 2.77%. The Zacks Consensus Estimate for ITGR’s 2025 earnings indicates a rise of 19.4%, while the consensus mark for revenues implies an improvement of 7.7% from the respective prior-year tallies. The consensus mark for ITGR’s 2025 earnings has moved 4.5% north in the past 60 days.

The bottom line of Align Technology outpaced estimates in each of the trailing four quarters, the average beat being 3.40%. The Zacks Consensus Estimate for ALGN’s 2025 earnings indicates a rise of 10.7%, while the consensus mark for revenues implies an improvement of 3.9% from the respective prior-year tallies. The consensus mark for ALGN’s 2025 earnings has moved 4.2% north in the past 60 days.

BioLife Solutions’ earnings outpaced estimates in each of the trailing four quarters, the average surprise being 112.90%. The Zacks Consensus Estimate for BLFS’ 2025 earnings is pegged at 2 cents per share. A loss of 7 cents per share was incurred in the prior-year quarter. BLFS has witnessed one upward estimate revision for 2025 earnings against none down in the past 60 days. 

Shares of Integer and BioLife Solutions have gained 2.8% and 3.3%, respectively, in the past year. However, Align Technology stock has lost 25.8% in the same time frame.  

Published in